These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15582885)

  • 1. [Locoregional recurrence of ovarian cancer: the place of surgery].
    Classe JM; Catala L; Marchal F; Ferron G; Dravet F; Pioud R; Descamps P
    Bull Cancer; 2004 Nov; 91(11):827-32. PubMed ID: 15582885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature.
    Bristow RE; Lagasse LD; Karlan BY
    Cancer; 1996 Nov; 78(10):2049-62. PubMed ID: 8918397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for recurrent ovarian cancer.
    Rose PG
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):17-23. PubMed ID: 10952122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary debulking surgery and intraperitoneal chemotherapy in advanced or recurrent epithelial ovarian cancer].
    Plaisant N; Quenet F; Fabbro M; Gourgou S; Gutowski M; Saint-Aubert B; Rouanet P
    Gynecol Obstet Fertil; 2004 May; 32(5):391-7. PubMed ID: 15177208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
    Munkarah AR; Coleman RL
    Gynecol Oncol; 2004 Nov; 95(2):273-80. PubMed ID: 15491746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
    Sugarbaker PH
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
    Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
    Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
    Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
    Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
    Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
    J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
    Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
    J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.
    Karam AK; Santillan A; Bristow RE; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Feb; 104(2):377-80. PubMed ID: 17014899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current surgical management in ovarian cancer recurrences].
    Tinelli FG; Tinelli A; Campagnutta E; Kobal B; Rakar S; Manca C; Tinelli R; Perrone A
    Minerva Ginecol; 2004 Oct; 56(5):457-67. PubMed ID: 15531862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
    Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
    Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of recurrent ovarian cancer.
    Leitao MM; Chi DS
    Semin Oncol; 2009 Apr; 36(2):106-11. PubMed ID: 19332245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of secondary cytoreductive surgery in epithelial ovarian malignancies.
    Williams L
    Oncology (Williston Park); 1992 Aug; 6(8):25-32; discussion 37-9. PubMed ID: 1386995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line treatment of first relapse recurrent ovarian cancer.
    Chua TC; Liauw W; Robertson G; Morris DL
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):465-71. PubMed ID: 21039382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
    Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
    Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.